All In Biotech

Drug Trial Radar · NCT02513550

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Ixekizumab Dosing Regimens in Patients With Moderate-to-Severe Plaque Psoriasis

Last checked: Nov 20, 2026Latest source record: Jun 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,257 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,257

Actual

Start

Aug 2015

Primary completion

Nov 2016

Study completion Aug 3, 2017

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jul 31, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the efficacy of ixekizumab dosing regimens in participants with plaque psoriasis.

Conditions

  • Plaque Psoriasis

Interventions

  • IxekizumabDrug

    Administered SQ

  • PlaceboDrug

    Administered SQ

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving Static Physician Global Assessment (sPGA) of (0,1)Time frame: Week 52
  2. Percentage of Participants Achieving 75% Improvement in Psoriasis Area and Severity Index (PASI 75)Time frame: Week 52

Locations

125 sites in 14 countries. Site status is shown where the registry gives one.

  • Total Skin and Beauty Dermatology Center PC

    Birmingham, Alabama

  • Anaheim Clinical Trials, LLC

    Anaheim, California

  • David Stoll, M.D.

    Beverly Hills, California

  • Dermatology Research Associates

    Los Angeles, California

  • Center for Dermatology and Laser Surgery

    Sacramento, California

  • Medical Center for Clinical Research

    San Diego, California

  • University Clinical Trials, Inc.

    San Diego, California

  • Clinical Science Institute

    Santa Monica, California

  • Cherry Creek Research, Inc

    Denver, Colorado

  • Florida Academic Dermatology Centers

    Coral Gables, Florida

  • Avail Clinical Research LLC

    DeLand, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Ameriderm Research

    Ormond Beach, Florida

  • University of South Florida

    Tampa, Florida

  • Advanced Medical Research

    Atlanta, Georgia

  • University Dermatology

    Darien, Illinois

  • Deaconess Clinic Inc

    Evansville, Indiana

  • Dawes Fretzin Clinical Research

    Indianapolis, Indiana

  • The South Bend Clinic

    South Bend, Indiana

  • Kansas City Dermatology, PA

    Overland Park, Kansas

  • Heartland Research Associates

    Wichita, Kansas

  • Dermatology Specialist

    Louisville, Kentucky

  • Dr. Shondra Smith MD

    Lake Charles, Louisiana

  • DermAssociates, P.C.

    Rockville, Maryland

  • ActivMed Practices & Research, Inc

    Beverly, Massachusetts

  • Central Dermatology PC

    St Louis, Missouri

  • ActivMed Practices & Research, Inc

    Newington, New Hampshire

  • Psoriasis Treatment Center of Central New Jersey

    East Windsor, New Jersey

  • Academic Dermatology Associates

    Albuquerque, New Mexico

  • Mount Sinai School of Medicine Dermatology Clinical Trials

    New York, New York

  • Skin Search of Rochester, Inc

    Rochester, New York

  • University of North Carolina Dermatology and Skin Cancer Center

    Chapel Hill, North Carolina

  • PMG Research of Wilmington, LLC

    Wilmington, North Carolina

  • Wilmington Dermatology Center

    Wilmington, North Carolina

  • Piedmont Medical Research

    Winston-Salem, North Carolina

  • University Hospitals of Cleveland

    Cleveland, Ohio

  • Healthcare Research Consultant

    Tulsa, Oklahoma

  • Oregon Dermatology and Research Center

    Portland, Oregon

  • Oregon Medical Research Center

    Portland, Oregon

Showing 40 of 125 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.